An end to smoking is within reach - it must not be allowed to ... - 16 November 2022 01:17

LONDON, Nov. 15, 2022 /PRNewswire-AsiaNet/-- In a landmark new Global State of Tobacco Harm Reduction (GSTHR) report, experts are calling on global policymakers to seize the opportunity to bring about an end to smoking, which every year kills eight million people worldwide. Despite years of ...

  Alphyn Biologics Completes First Cohort of Phase2a Clinical Tr... - 15 November 2022 23:30

ANNAPOLIS, Md., Nov. 15, 2022 /PRNewswire-AsiaNet/ -- Alphyn Biologics ( https://c212.net/c/link/?t=0&l=en&o=3709054-1&h=2795132862&u=https%3A%2F%2Falphynbiologics.com%2F&a=Alphyn+Biologics ), a clinical-stage dermatology company developing first-in-class multi-target therapeutics, announced today th...

  LumiraDx Continues Commercial Expansion of its Rapid Microflui... - 15 November 2022 03:14

LONDON, November 14, 2021 /PRNewswire-AsiaNet/-- - Now Available in Europe, parts of the Middle East, Asia, Latin America, and Africa - Early customers include GP offices and other community-based healthcare settings - Latest figures, released as part of World Diabetes Day, reveal that 1 ...

  RedHill Accelerates Opaganib's Nuclear Radiation Protection Pr... - 15 November 2022 00:44

TEL AVIV, Israel and RALEIGH, NC, November 14, 2022 /PRNewswire-AsiaNet/ -- Strong preclinical data, recently published in the International Journal of Molecular Sciences, from eight U.S government-funded in-vivo opaganib studies, supports opaganib's potential as a nuclear radiation injury therapeutic for homeland securit...

  SENTINEL DIAGNOSTICS LAUNCHES SENTINAT(R) 200, THE FULLY AUTOM... - 14 November 2022 20:00

MILAN, November, 14, 2022, /PRNewswire-AsiaNet/-- Sentinel CH. SpA today announced the launch of SENTiNAT(R) 200, the fully automated sample to result system, and SENT-NAT(R) SN200 Real-Time PCR assays for the quantitative detection of 10 viruses. SENTiNAT(R) 200 and STAT-NAT(R) SN200 kits repres...

  TauRx Announces Additional Investment of USD119 million follow... - 14 November 2022 18:00

ABERDEEN, Scotland and SINGAPORE, Nov. 14, 2022 /PRNewswire-AsiaNet/ -- - Substantial investment of USD119 million achieved by TauRx through a warrants exercise triggered by the announcement of LUCIDITY results in October, supporting HMTM regulatory submissions in UK, US and Canada, and preparation for market availabi...

  LOTUS REPORTS ITS BEST QUARTER EVER WITH THE BIGGEST LAUNCH IN... - 11 November 2022 21:00

TAIPEI, Taiwan, Nov. 11, 2022 /PRNewswire-AsiaNet/ -- Lotus Pharmaceutical (1795: TT), a multinational pharmaceutical company, today reported its financial results for the third quarter ended 30 September 2022. Third quarter financial highlights: - Third quarter 2022 is the best quarter ever in...

  TES Pharma Congratulates Intercept Pharmaceuticals on their Pr... - 09 November 2022 11:00

PERUGIA, Italy, Nov. 9, 2022, /PRNewswire-AsiaNet/-- INT-787 is a selective next generation FXR agonist invented by TES Pharma and licensed to Intercept Pharmaceuticals INT-787 has shown strong anti-fibrotic and anti-inflammatory effects in animal models TES Pharma is dedicated to the identifi...

  Novavax Phase 3 COVID-19 Omicron Trial Supports the Continued ... - 09 November 2022 01:51

GAITHERSBURG, Md., Nov. 8, 2022 /PRNewswire-AsiaNet/ -- -- The Novavax BA.1 vaccine candidate met its primary strain-change endpoint allowing for development of variant vaccines, if necessary -- Novavax' prototype vaccine induced broad immune response against original Wuhan, BA.1, and BA.5 strains --...

  EIT Health's Venture Centre of Excellence Names ProductLife Gr... - 08 November 2022 20:00

PARIS, Nov. 8, 2022 /PRNewswire-AsiaNet/ -- - The ambitious EU initiative has already secured 2 billion euros of co-investment capabilities and has supported 60 innovative Biotech, Medtech & digital health start-ups to get to market or expand into new territories. - EIT Health, co-operator...